Clicky

LIFETECH SCI.DL-00000125(81X)

Description: LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders worldwide. The company operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. Its products include LAmbre left atrial appendage closure systems, as well as CeraFlex, Cera, HeartR, and Konar-MF VSD occluders; Ankura thoracic aortic aneurysm and abdominal aortic aneurysm stent graft systems; Futhrough endovascular needle systems; delivery systems, such as Fustar steerable and SteerEase introducers; Zoetrack guidewire; Aegisy vena cava filters; Cera vascular plug systems; AcuMark sizing balloons; HearTone implantable cardiac pacing system; and SeQure snare systems, as well as pacemakers. The company is also involved in the biomedical research and development; properties leasing business; and manufacturing and trading of medical devices, as well as offers technical, consulting, and technology services. The company was founded in 1999 and is headquartered in Shenzhen, China.


Keywords: Medical Device Technology Services Disorders Stent Interventional Radiology Vascular Disease Cardiac Electrophysiology Vascular Surgery Peripheral Artery Disease Aneurysm Aortic Aneurysm Abdominal Aortic Aneurysm Artificial Cardiac Pacemaker Cardiovascular And Peripheral Vascular Diseases Thoracic Aortic Aneurysm Abdominal Aortic Aneurysm Stent Graft Systems Interventional Medical Devices Left Atrial Appendage Closure Systems Vascular Plug Systems

Home Page: www.lifetechmed.com

LifeTech Scientific Building
Shenzhen, 518063
China
Phone: 86 75 5860 26250


Officers

Name Title
Mr. Yuehui Xie Chairman & CEO
Mr. Jianxiong Liu ACCA CFO, Executive VP, Company Secretary & Executive Director

Exchange: F

Country: DE : Germany

Currency: Euro (€)

Forward PE: 0
Trailing PE: 15.7
Price-to-Book MRQ: 1.5513
Price-to-Sales TTM: 0.6256
IPO Date:
Fiscal Year End: December
Full Time Employees: 1414
Back to stocks